What is known about UFL1 (RCAD) and UFL1‑mediated UFMylation (attachment of ubiquitin‑like modifier UFM1)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

UFL1 and UFL1-Mediated UFMylation

UFL1 (also known as RCAD) is the sole E3 ligase in the UFMylation pathway, a post-translational modification system that covalently attaches the ubiquitin-like modifier UFM1 to target proteins, playing critical roles in cellular stress responses, protein quality control, and tissue homeostasis.

The UFMylation System Architecture

The UFMylation pathway operates through a sequential enzymatic cascade analogous to ubiquitination 1:

  • E1 enzyme: UBA5 (activating enzyme)
  • E2 enzyme: UFC1 (conjugating enzyme)
  • E3 ligase: UFL1 (the sole ligase, working with UFBP1 and CDK5RAP3 as adaptor proteins)
  • Deconjugating enzymes: UFSP1 and UFSP2 (remove UFM1 from substrates)

UFL1 forms a functional E3 complex with UFBP1 and CDK5RAP3, which is essential for substrate recognition and UFM1 conjugation 2.

Cellular Functions and Mechanisms

Protein Quality Control at the ER

UFL1-mediated UFMylation is fundamentally involved in ER-associated protein quality control mechanisms 2. The E3 complex:

  • Associates with ribosomal protein RPL26 (the most abundant UFMylation substrate)
  • Participates in ribosome-associated quality control (RQC) at the ER
  • Responds to disome formation during translation stalling
  • Maintains proteostasis through coordinated substrate modification

Protein Stabilization Through Competitive Modification

A recurring mechanistic theme is that UFMylation antagonizes ubiquitination to prevent proteasomal degradation 3, 4:

  • IFT88: UFMylation at lysine 572 by UFL1 prevents ubiquitination by PJA2, maintaining ciliary homeostasis 3
  • RUNX2: UFL1-mediated UFMylation stabilizes this master regulator of amelogenesis 4
  • ABI5: UFMylation antagonizes ubiquitination to stabilize this transcription factor in ABA signaling (plant model) 5

This represents a critical regulatory mechanism where UFMylation competes with ubiquitination at specific lysine residues.

Biological Significance and Disease Relevance

Tissue-Specific Functions

UFL1 deficiency causes severe phenotypes across multiple systems 3, 4, 1:

  • Ciliary defects: Loss of UFL1 disrupts ciliary structure and function in multiple tissues
  • Amelogenesis imperfecta: Epithelial-specific UFL1 knockout causes severe enamel defects with hypomineralization
  • ER stress responses: UFMylation regulates cellular adaptation to ER stress
  • DNA damage repair and autophagy: The system participates in broader stress surveillance

Disease Associations

Dysregulation of the UFM1 conjugation system contributes to 1:

  • Inflammatory diseases
  • Malignant tumors
  • Hematopoietic defects
  • Neurodegenerative disorders
  • Congenital developmental defects

Technical Considerations for Research

Substrate Identification Challenges

The field faces significant technical limitations 6:

  • RPL26 masking: The overwhelming abundance of RPL26-UFM1 conjugates obscures low-abundance substrates
  • Detection sensitivity: Conventional methods have poor efficiency

Optimized Detection Protocol

The most effective approach for identifying UFMylation substrates involves 6:

  1. Generate UFSP1/UFSP2 double-knockout cells (eliminates de-UFMylation)
  2. Express mature UFM1-ΔC2 exogenously
  3. Co-express UFL1 and DDRGK1 to enhance sensitivity
  4. Use K-ε-VG antibody enrichment
  5. Perform LC-MS/MS analysis for large-scale substrate identification
  6. Validate sites through mutagenesis and UFSP2-mediated de-UFMylation

Key Mechanistic Insights

The UFL1 E3 complex functions as a molecular switch that determines protein fate by:

  • Competing with ubiquitin E3 ligases at specific lysine residues
  • Stabilizing substrates against proteasomal degradation
  • Coordinating stress responses at the ER
  • Maintaining tissue-specific homeostasis through substrate-specific modifications

The localization of UFL1 to both nucleus and cytoplasm 5 enables it to regulate diverse cellular processes, while its tissue-specific expression patterns (particularly during embryogenesis and seed maturation in plants) suggest developmental regulation 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.